Donor organizations poured millions of dollars into U.S. firm Cepheid’s diagnostic equipment to tackle disease in poor countries. When COVID-19 struck, the system fell apart.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
Diagnostics company Cepheid overcharging and undersupplying critical COVID-19 test | 0 | 573 | July 28, 2020 | |
Africa's struggle with inadequate COVID-19 testing | 0 | 456 | May 26, 2020 | |
COVID-19 diagnostics—not at the expense of other diseases | 0 | 549 | June 8, 2020 | |
Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing | 0 | 345 | September 2, 2021 | |
Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho | 0 | 465 | August 2, 2023 |